Tamrintamab structure
|
Common Name | Tamrintamab | ||
|---|---|---|---|---|
| CAS Number | 2148325-59-9 | Molecular Weight | N/A | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | N/A | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of TamrintamabTamrintamab (SC-003 mAb, SC-Mab003, SC34.28ss1) is an ADC Antibody targeting to dipeptidase 3 (DPEP3 or MBD3). DPEP3 is a glycosyl phosphatidylinositol anchored metallopeptidase that is overexpressed in ovarian tumors. Tamrintamab can specifically bind DPEP3-expressing cells to produce cytotoxicity. Tamrintamab can be used in ovarian cancer research[1][2]. |
| Name | Tamrintamab |
|---|
| Description | Tamrintamab (SC-003 mAb, SC-Mab003, SC34.28ss1) is an ADC Antibody targeting to dipeptidase 3 (DPEP3 or MBD3). DPEP3 is a glycosyl phosphatidylinositol anchored metallopeptidase that is overexpressed in ovarian tumors. Tamrintamab can specifically bind DPEP3-expressing cells to produce cytotoxicity. Tamrintamab can be used in ovarian cancer research[1][2]. |
|---|---|
| Related Catalog | |
| In Vitro | Tamrintamab is a monoclonal antibody targeting dipeptidase 3 (DPEP3 or MBD3) via a maleimide splice cleavable by protease[1]. |
| References |
| No Any Chemical & Physical Properties |